Blood Preparation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
The global blood preparation market size reached US$ 40.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 53.8 Billion by 2027, exhibiting a growth rate (CAGR) of 5.4% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
Blood donation is a lifesaving procedure wherein one unit of blood is taken from the donor. This blood consists of a mixture of cellular elements, colloids, and crystalloids, which need to be separated for being used in patients. As a result, the blood preparation method is widely adopted to separate one-unit whole blood into different components using refrigerated centrifuge equipment. These components generally include cryoprecipitate, platelet concentrate, fresh frozen plasma, and packed red blood cell (PRBC) concentrate. The blood preparation method also maximizes the utility of each blood component for a different applications.
Blood Preparation Market Trends:
Due to the surging cases of coronavirus disease (COVID-19) and the lack of effective treatment, several hospitals are relying on convalescent plasma as a promising treatment for patients with critical conditions. This represents one of the key factors positively influencing the need for blood preparation methods to separate plasma from healthy blood donations. Apart from this, the growing prevalence of chronic disorders, such as anemia, sickle cell disease, hemophilia, and cancer, is catalyzing the demand for blood transfusion. This, in confluence with the rising number of blood donors on account of awareness campaigns conducted by governmental and non-governmental organizations (NGOs) worldwide, is contributing to the market growth. In line with this, a significant rise in the number of surgical procedures is also bolstering the growth of the market. Moreover, several healthcare institutions are focusing on employing advanced digital technologies for the speedy separation of blood components. They are also utilizing radio frequency identification (RFID) technology for maintaining blood inventory records, which is anticipated to expand the application of blood preparation methods in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global blood preparation market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, antithrombotic and anticoagulants type, and antithrombotic and anticoagulants application.
Breakup by Product:
Whole Blood
Red Cells
Granulocytes
Plasma
Platelets
Blood Components
Whole Blood Components
Packed Red Cells
Leukocyte Reduced Red Blood Cells
Frozen Plasma
Platelet Concentrate
Cryoprecipitate
Blood Derivatives
Breakup by Antithrombotic and Anticoagulants Type:
Platelet Aggregation Inhibitors
Glycoprotein Inhibitors
COX Inhibitors
ADP Antagonists
Others
Fibrinolytics
Tissue Plasminogen Activator (TPA)
Streptokinase
Urokinase
Anticoagulants
Heparins
Vitamin K Antagonists
Direct Thrombin Inhibitors
Direct Factor Xa Inhibitors
Breakup by Antithrombotic and Anticoagulants Application:
Thrombocytosis
Pulmonary Embolism
Renal Impairment
Angina Blood Vessel Complications
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Baxter International Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, GlaxoSmithKline PLC, Johnson & Johnson Services Inc., LEO Pharma A/S, Pfizer Inc., Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.) and Sanofi S.A.
Key Questions Answered in This Report:
How has the global blood preparation market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global blood preparation market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the antithrombotic and anticoagulants type?
What is the breakup of the market based on the antithrombotic and anticoagulants application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global blood preparation market and who are the key players?
What is the degree of competition in the industry?
Blood donation is a lifesaving procedure wherein one unit of blood is taken from the donor. This blood consists of a mixture of cellular elements, colloids, and crystalloids, which need to be separated for being used in patients. As a result, the blood preparation method is widely adopted to separate one-unit whole blood into different components using refrigerated centrifuge equipment. These components generally include cryoprecipitate, platelet concentrate, fresh frozen plasma, and packed red blood cell (PRBC) concentrate. The blood preparation method also maximizes the utility of each blood component for a different applications.
Blood Preparation Market Trends:
Due to the surging cases of coronavirus disease (COVID-19) and the lack of effective treatment, several hospitals are relying on convalescent plasma as a promising treatment for patients with critical conditions. This represents one of the key factors positively influencing the need for blood preparation methods to separate plasma from healthy blood donations. Apart from this, the growing prevalence of chronic disorders, such as anemia, sickle cell disease, hemophilia, and cancer, is catalyzing the demand for blood transfusion. This, in confluence with the rising number of blood donors on account of awareness campaigns conducted by governmental and non-governmental organizations (NGOs) worldwide, is contributing to the market growth. In line with this, a significant rise in the number of surgical procedures is also bolstering the growth of the market. Moreover, several healthcare institutions are focusing on employing advanced digital technologies for the speedy separation of blood components. They are also utilizing radio frequency identification (RFID) technology for maintaining blood inventory records, which is anticipated to expand the application of blood preparation methods in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global blood preparation market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, antithrombotic and anticoagulants type, and antithrombotic and anticoagulants application.
Breakup by Product:
Whole Blood
Red Cells
Granulocytes
Plasma
Platelets
Blood Components
Whole Blood Components
Packed Red Cells
Leukocyte Reduced Red Blood Cells
Frozen Plasma
Platelet Concentrate
Cryoprecipitate
Blood Derivatives
Breakup by Antithrombotic and Anticoagulants Type:
Platelet Aggregation Inhibitors
Glycoprotein Inhibitors
COX Inhibitors
ADP Antagonists
Others
Fibrinolytics
Tissue Plasminogen Activator (TPA)
Streptokinase
Urokinase
Anticoagulants
Heparins
Vitamin K Antagonists
Direct Thrombin Inhibitors
Direct Factor Xa Inhibitors
Breakup by Antithrombotic and Anticoagulants Application:
Thrombocytosis
Pulmonary Embolism
Renal Impairment
Angina Blood Vessel Complications
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Baxter International Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, GlaxoSmithKline PLC, Johnson & Johnson Services Inc., LEO Pharma A/S, Pfizer Inc., Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.) and Sanofi S.A.
Key Questions Answered in This Report:
How has the global blood preparation market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global blood preparation market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the antithrombotic and anticoagulants type?
What is the breakup of the market based on the antithrombotic and anticoagulants application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global blood preparation market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL BLOOD PREPARATION MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Whole Blood
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Red Cells
6.1.2.2 Granulocytes
6.1.2.3 Plasma
6.1.2.4 Platelets
6.1.3 Market Forecast
6.2 Blood Components
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Whole Blood Components
6.2.2.2 Packed Red Cells
6.2.2.3 Leukocyte Reduced Red Blood Cells
6.2.2.4 Frozen Plasma
6.2.2.5 Platelet Concentrate
6.2.2.6 Cryoprecipitate
6.2.3 Market Forecast
6.3 Blood Derivatives
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY ANTITHROMBOTIC AND ANTICOAGULANTS TYPE
7.1 Platelet Aggregation Inhibitors
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Glycoprotein Inhibitors
7.1.2.2 COX Inhibitors
7.1.2.3 ADP Antagonists
7.1.2.4 Others
7.1.3 Market Forecast
7.2 Fibrinolytics
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Tissue Plasminogen Activator (TPA)
7.2.2.2 Streptokinase
7.2.2.3 Urokinase
7.2.3 Market Forecast
7.3 Anticoagulants
7.3.1 Market Trends
7.3.2 Key Segments
7.3.2.1 Heparins
7.3.2.2 Vitamin K Antagonists
7.3.2.3 Direct Thrombin Inhibitors
7.3.2.4 Direct Factor Xa Inhibitors
7.3.3 Market Forecast
8 MARKET BREAKUP BY ANTITHROMBOTIC AND ANTICOAGULANTS APPLICATION
8.1 Thrombocytosis
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Pulmonary Embolism
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Renal Impairment
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Angina Blood Vessel Complications
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Baxter International Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Boehringer Ingelheim International GmbH
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Bristol-Myers Squibb Company
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Daiichi Sankyo Company Limited
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 GlaxoSmithKline PLC
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Johnson & Johnson Services Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 LEO Pharma A/S
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 SWOT Analysis
14.3.8 Pfizer Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.)
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Sanofi S.A.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL BLOOD PREPARATION MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Whole Blood
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Red Cells
6.1.2.2 Granulocytes
6.1.2.3 Plasma
6.1.2.4 Platelets
6.1.3 Market Forecast
6.2 Blood Components
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Whole Blood Components
6.2.2.2 Packed Red Cells
6.2.2.3 Leukocyte Reduced Red Blood Cells
6.2.2.4 Frozen Plasma
6.2.2.5 Platelet Concentrate
6.2.2.6 Cryoprecipitate
6.2.3 Market Forecast
6.3 Blood Derivatives
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY ANTITHROMBOTIC AND ANTICOAGULANTS TYPE
7.1 Platelet Aggregation Inhibitors
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Glycoprotein Inhibitors
7.1.2.2 COX Inhibitors
7.1.2.3 ADP Antagonists
7.1.2.4 Others
7.1.3 Market Forecast
7.2 Fibrinolytics
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Tissue Plasminogen Activator (TPA)
7.2.2.2 Streptokinase
7.2.2.3 Urokinase
7.2.3 Market Forecast
7.3 Anticoagulants
7.3.1 Market Trends
7.3.2 Key Segments
7.3.2.1 Heparins
7.3.2.2 Vitamin K Antagonists
7.3.2.3 Direct Thrombin Inhibitors
7.3.2.4 Direct Factor Xa Inhibitors
7.3.3 Market Forecast
8 MARKET BREAKUP BY ANTITHROMBOTIC AND ANTICOAGULANTS APPLICATION
8.1 Thrombocytosis
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Pulmonary Embolism
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Renal Impairment
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Angina Blood Vessel Complications
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Baxter International Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Boehringer Ingelheim International GmbH
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Bristol-Myers Squibb Company
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Daiichi Sankyo Company Limited
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 GlaxoSmithKline PLC
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Johnson & Johnson Services Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 LEO Pharma A/S
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 SWOT Analysis
14.3.8 Pfizer Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.)
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Sanofi S.A.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Blood Preparation Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Blood Preparation Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Blood Preparation Market Forecast: Breakup by Antithrombotic and Anticoagulants Type (in Million US$), 2022-2027
Table 4: Global: Blood Preparation Market Forecast: Breakup by Antithrombotic and Anticoagulants Application (in Million US$), 2022-2027
Table 5: Global: Blood Preparation Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Blood Preparation Market: Competitive Structure
Table 7: Global: Blood Preparation Market: Key Players
Table 1: Global: Blood Preparation Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Blood Preparation Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Blood Preparation Market Forecast: Breakup by Antithrombotic and Anticoagulants Type (in Million US$), 2022-2027
Table 4: Global: Blood Preparation Market Forecast: Breakup by Antithrombotic and Anticoagulants Application (in Million US$), 2022-2027
Table 5: Global: Blood Preparation Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Blood Preparation Market: Competitive Structure
Table 7: Global: Blood Preparation Market: Key Players
LIST OF FIGURES
Figure 1: Global: Blood Preparation Market: Major Drivers and Challenges
Figure 2: Global: Blood Preparation Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Blood Preparation Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Blood Preparation Market: Breakup by Product (in %), 2021
Figure 5: Global: Blood Preparation Market: Breakup by Antithrombotic and Anticoagulants Type (in %), 2021
Figure 6: Global: Blood Preparation Market: Breakup by Antithrombotic and Anticoagulants Application (in %), 2021
Figure 7: Global: Blood Preparation Market: Breakup by Region (in %), 2021
Figure 8: Global: Blood Preparation (Whole Blood) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Blood Preparation (Whole Blood) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Blood Preparation (Blood Components) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Blood Preparation (Blood Components) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Blood Preparation (Blood Derivatives) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Blood Preparation (Blood Derivatives) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Blood Preparation (Platelet Aggregation Inhibitors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Blood Preparation (Platelet Aggregation Inhibitors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Blood Preparation (Fibrinolytics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Blood Preparation (Fibrinolytics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Blood Preparation (Anticoagulants) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Blood Preparation (Anticoagulants) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Blood Preparation (Thrombocytosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Blood Preparation (Thrombocytosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Blood Preparation (Pulmonary Embolism) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Blood Preparation (Pulmonary Embolism) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Blood Preparation (Renal Impairment) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Blood Preparation (Renal Impairment) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Blood Preparation (Angina Blood Vessel Complications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Blood Preparation (Angina Blood Vessel Complications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Blood Preparation (Other Antithrombotic and Anticoagulant Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Blood Preparation (Other Antithrombotic and Anticoagulant Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: North America: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: North America: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: United States: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: United States: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Canada: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Canada: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Asia-Pacific: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Asia-Pacific: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: China: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: China: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Japan: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Japan: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: India: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: India: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: South Korea: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: South Korea: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Australia: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Australia: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Indonesia: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Indonesia: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Others: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Others: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Europe: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Europe: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Germany: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Germany: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: France: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: France: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: United Kingdom: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: United Kingdom: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Italy: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Italy: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Spain: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Spain: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Russia: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Russia: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Others: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Others: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Latin America: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Latin America: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Brazil: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Brazil: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Mexico: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Mexico: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Others: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Others: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Middle East and Africa: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Middle East and Africa: Blood Preparation Market: Breakup by Country (in %), 2021
Figure 78: Middle East and Africa: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Global: Blood Preparation Industry: SWOT Analysis
Figure 80: Global: Blood Preparation Industry: Value Chain Analysis
Figure 81: Global: Blood Preparation Industry: Porter's Five Forces Analysis
Figure 1: Global: Blood Preparation Market: Major Drivers and Challenges
Figure 2: Global: Blood Preparation Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Blood Preparation Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Blood Preparation Market: Breakup by Product (in %), 2021
Figure 5: Global: Blood Preparation Market: Breakup by Antithrombotic and Anticoagulants Type (in %), 2021
Figure 6: Global: Blood Preparation Market: Breakup by Antithrombotic and Anticoagulants Application (in %), 2021
Figure 7: Global: Blood Preparation Market: Breakup by Region (in %), 2021
Figure 8: Global: Blood Preparation (Whole Blood) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Blood Preparation (Whole Blood) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Blood Preparation (Blood Components) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Blood Preparation (Blood Components) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Blood Preparation (Blood Derivatives) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Blood Preparation (Blood Derivatives) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Blood Preparation (Platelet Aggregation Inhibitors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Blood Preparation (Platelet Aggregation Inhibitors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Blood Preparation (Fibrinolytics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Blood Preparation (Fibrinolytics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Blood Preparation (Anticoagulants) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Blood Preparation (Anticoagulants) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Blood Preparation (Thrombocytosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Blood Preparation (Thrombocytosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Blood Preparation (Pulmonary Embolism) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Blood Preparation (Pulmonary Embolism) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Blood Preparation (Renal Impairment) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Blood Preparation (Renal Impairment) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Blood Preparation (Angina Blood Vessel Complications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Blood Preparation (Angina Blood Vessel Complications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Blood Preparation (Other Antithrombotic and Anticoagulant Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Blood Preparation (Other Antithrombotic and Anticoagulant Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: North America: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: North America: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: United States: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: United States: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Canada: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Canada: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Asia-Pacific: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Asia-Pacific: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: China: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: China: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Japan: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Japan: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: India: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: India: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: South Korea: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: South Korea: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Australia: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Australia: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Indonesia: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Indonesia: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Others: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Others: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Europe: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Europe: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Germany: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Germany: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: France: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: France: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: United Kingdom: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: United Kingdom: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Italy: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Italy: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Spain: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Spain: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Russia: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Russia: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Others: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Others: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Latin America: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Latin America: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Brazil: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Brazil: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Mexico: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Mexico: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Others: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Others: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Middle East and Africa: Blood Preparation Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Middle East and Africa: Blood Preparation Market: Breakup by Country (in %), 2021
Figure 78: Middle East and Africa: Blood Preparation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Global: Blood Preparation Industry: SWOT Analysis
Figure 80: Global: Blood Preparation Industry: Value Chain Analysis
Figure 81: Global: Blood Preparation Industry: Porter's Five Forces Analysis
